NasdaqGS:UTMDMedical Equipment
Utah Medical Products (UTMD) Margin Compression Challenges Bullish Valuation Narratives Heading Into Q1 2026
Utah Medical Products (UTMD) has just opened Q1 2026 reporting season with a backdrop of steady recent financials, capped by Q4 2025 revenue of about US$9.0 million and basic EPS of roughly US$0.80, supported by trailing 12 month totals of US$38.5 million in revenue and EPS of about US$3.48. Over the past few quarters, the company has seen quarterly revenue range between roughly US$9.0 million and US$10.0 million, with basic EPS moving between about US$0.80 and US$1.02. Trailing 12 month net...